Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Psychiatry Research

• Publication date

  2010-01-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psychres.2009.01.013PMID 19969375
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia.

  2008cited by this paper
• Polymorphisms in the catechol‐O‐methyltransferase (COMT) gene influence plasma total homocysteine levels

  2008cited by this paper
• Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients.

  2008cited by this paper
• No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients.

  2008cited by this paper
• Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.

  2008cited by this paper
• Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications.

  2007cited by this paper
• Homocysteine and its Derivatives as Possible Modulators of Neuronal and Non-Neuronal Cell Glutamate Receptors in Alzheimer's Disease

  2007cited by this paper
• Plasma homocysteine, folate and B12 in chronic schizophrenia.

  2007cited by this paper
• The effect of gender on emotion perception in schizophrenia and bipolar disorder

  2007cited by this paper
• Brain derived neurotropic factor in first-episode psychosis.

  2007cited by this paper
• The Role of One‐Carbon Metabolism in Schizophrenia and Depression

  2007influential reference
• Increased Levels of Nitric Oxide, Cortisol and Adrenomedullin in Patients with Chronic Schizophrenia

  2007cited by this paper
• Elevated prenatal homocysteine levels as a risk factor for schizophrenia.

  2007cited by this paper
• Schizophrenia and Liver Dysfunction Caused by Portacaval Shunting

  2007cited by this paper
• The relationship between folate and docosahexaenoic acid in men

  2006cited by this paper
• Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.

  2006cited by this paper
• Maternal folic acid supplementation to dams on marginal protein level alters brain fatty acid levels of their adult offspring.

  2006cited by this paper
• Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation.

  2006cited by this paper
• Aberrant folate status in schizophrenic patients: what is the evidence?

  2005influential reference
• Relationship between cognition and work functioning among patients with schizophrenia in an urban area of India.

  2005cited by this paper
• Nutritional and life style determinants of plasma homocysteine in schizophrenia patients.

  2005influential reference
• Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: A pilot investigation

  2005cited by this paper
• Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses.

  2005cited by this paper
• Do Maternal Folate and Homocysteine Levels Play a Role in Neurodevelopmental Processes That Increase Risk for Schizophrenia?

  2005cited by this paper
• Treatment of depression: time to consider folic acid and vitamin B12

  2005cited by this paper
• Plasma Folate and Homocysteine Levels May Be Related to Interictal "Schizophrenia-Like" Psychosis in Patients With Epilepsy

  2005cited by this paper
• The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia.

  2005cited by this paper
• Schizophrenia and single-carbon metabolism.

  2005cited by this paper
• Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report

  2005cited by this paper
• Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics.

  2004influential reference
• Folate, homocysteine, and negative symptoms in schizophrenia.

  2004influential reference
• Homocysteine levels in newly admitted schizophrenic patients.

  2004cited by this paper
• Twenty-Year Course of Schizophrenia: The Madras Longitudinal Study

  2004influential reference
• Folate intake and risk of Parkinson's disease.

  2004cited by this paper
• Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia.

  2003cited by this paper
• Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients.

  2003cited by this paper
• Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

  2003cited by this paper
• Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment.

  2003cited by this paper
• Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients.

  2003cited by this paper
• Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.

  2003cited by this paper
• Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites.

  2002cited by this paper
• Determination of total homocysteine in plasma: comparison of the Abbott IMx immunoassay with high performance liquid chromatography.

  2002cited by this paper
• Elevated homocysteine levels in young male patients with schizophrenia.

  2002cited by this paper
• Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.

  2002influential reference
• Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.

  2001cited by this paper
• Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia.

  2001cited by this paper
• Schizophrenia and liver dysfunction.

  2001cited by this paper
• Oxidative Damage and Schizophrenia

  2001cited by this paper
• Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia

  2001cited by this paper
• Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia.

  2000cited by this paper
• Vitamin B12 levels are low in hospitalized psychiatric patients.

  2000influential reference
• Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia.

  2000cited by this paper
• Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia.

  2000cited by this paper
• Folate Administration Increases n-3 Polyunsaturated Fatty Acids in Rat Plasma and Tissue Lipids

  2000cited by this paper
• Folate levels in psychiatric outpatients

  1999cited by this paper
• A prevalence study of folate deficiency in a psychiatric in‐patient population

  1998cited by this paper
• Schizophrenia and impaired homocysteine metabolism: a possible association.

  1998cited by this paper
• Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor.

  1997cited by this paper
• Disturbances of one-carbon metabolism in neuropsychiatric disorders: a review.

  1997cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.

  1994cited by this paper
• Do essential fatty acids play a role in brain and behavioral development?

  1992cited by this paper
• Fatty acid levels in the brains of schizophrenics and normal controls.

  1991cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Fatty acids in plasma and red cell membranes of normal and hyperlipoproteinemic subjects

  1985cited by this paper
• Human serum vitamin B12 assay methods--a review.

  1985cited by this paper
• The transmethylation and one-carbon cycle hypotheses of schizophrenia

  1983cited by this paper
• Fatty acids in plasma and red cell membranes in normal humans

  1983cited by this paper
• AN IMMUNOASSAY FOR PLASMA CORTISOL BASED ON CHEMILUMINESCENCE

  1981cited by this paper
• Highlights of the National Institutes of Health Program in Biomedical and Behavioral Nutrition and Research Training--with the emphasis on total parenteral and enteral nutrition.

  1981cited by this paper
• An immunoassay for plasma cortisol based on chemiluminescence.

  1980cited by this paper
• Schizophrenia: a new approach.

  1952cited by this paper
• Schizophrenia: a new approach.

  1952cited by this paper

• Metabolic Mechanisms in Electroconvulsive Therapy for Schizophrenia: Role, Potential and Future Directions.

  2026cites this paper
• THE ROLE OF DIETARY PATTERNS AND NUTRIENTS IN SCHIZOPHRENIA: A LITERATURE REVIEW

  2025cites this paper
• A comprehensive review on schizophrenia: epidemiology, pathogenesis, diagnosis, conventional treatments, and proposed natural compounds used for management

  2025cites this paper
• Steroids and One-Carbon Metabolism: Clinical Implications in Endocrine Disorders

  2025cites this paper
• Excess maternal vitamin B12 supplementation increases oxidative stress and differentially influences fatty acids profile in a rat model.

  2025cites this paper
• Hyperhomocysteinemia in chronic schizophrenia: prevalence, clinical correlates, and paradoxical associations with symptom severity.

  2025cites this paper
• One‑carbon nutrients and genistein as nutritional programming effectors in juvenile gilthead seabream (Sparus aurata): Contrasting effects on phenotypic traits

  2024cites this paper
• Homicide or Happiness: Did Folate Fortification and Public Health Campaigns Influence Homicide Rates and the Great American Crime Decline?

  2024cites this paper
• Vitamins B9 and B12 in children with attention deficit hyperactivity disorder (ADHD).

  2024cites this paper
• Navigating Nutritional Inequality in Schizophrenia: A Comprehensive Exploration of Diet, Genetics, and Holistic Management Across the Life Cycle

  2024cites this paper
• Schizophrenia as metabolic disease. What are the causes?

  2023cites this paper
• IL-6, homocysteine, and autism spectrum phenotypes: an investigation among adults with autism spectrum disorder and their first-degree relatives

  2023cites this paper
• Abnormalities in one-carbon metabolism in young patients with psychosis

  2023cites this paper
• Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis.

  2023cites this paper
• Blood–brain barrier dysfunction and folate and vitamin B12 levels in first-episode schizophrenia-spectrum psychosis: a retrospective chart review

  2023cites this paper
• “Severe Anemia: A Case Report of an Uncommon Precipitant of Schizophrenia Relapse”

  2023cites this paper
• The positive association between antipsychotic-induced weight gain and therapeutic response: New biotypes of schizophrenia.

  2023cites this paper
• Study of Homocysteine, Vitamin B12 and Folate in children with autism spectrum disorder

  2023cites this paper
• Altered expression of nutrient transporters in syncytiotrophoblast membranes in preeclampsia placentae.

  2023cites this paper
• Clinical efficacy and safety of folic acid and vitamin B12 for the adjuvant treatment of schizophrenia: a systematic review and meta-analysis.

  2023cites this paper
• Sulfur-containing amino acids and risk of schizophrenia.

  2023cites this paper
• Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders

  2023cites this paper
• Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis

  2022cites this paper
• Relationship of serum homocysteine and vitamin D with positive, negative, and extrapyramidal symptoms in schizophrenia: a case–control study in Iran

  2022cites this paper
• EFFECT OF ADDING DRY YEAST AND FOLIC ACID ON IMPROVING THE PHYSIOLOGICAL AND PRODUCTIVE PERFORMANCE OF QUAIL.

  2022cites this paper
• A sensitive UPLC-MS/MS method for simultaneous quantification of one-carbon metabolites & co-factors in human plasma.

  2022cites this paper
• Influence of maternal one carbon metabolites on placental programming and long term health.

  2022cites this paper
• Prenatal methotrexate injection increases behaviors possibly associated with depression and/or autism in rat offspring; A new animal model for mental disorder, based on folate metabolism deficit during pregnancy

  2022cites this paper
• Halting the Metabolic Complications of Antipsychotic Medication in Patients with a First Episode of Psychosis: How Far Can We Go with the Mediterranean Diet? A Pilot Study

  2022cites this paper
• The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics

  2022cites this paper
• A High-Methionine Diet for One-Week Induces a High Accumulation of Methionine in the Cerebrospinal Fluid and Confers Bipolar Disorder-like Behavior in Mice

  2022cites this paper
• A meta-analysis of blood and salivary cortisol levels in first-episode psychosis and high-risk individuals.

  2021influential citation
• The Effect of B9 and B12 Vitamins Deficiency on Hypomethylation of MMP-9 gene Promoter Among Women With Preterm Parturition

  2021cites this paper
• Scrutinizing the causal relationship between schizophrenia and vitamin supplementation: a Mendelian randomization study

  2021cites this paper
• Folic acid, vitamin B12, and psychotic symptoms among young psychiatric inpatients

  2021cites this paper
• Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex

  2021cites this paper
• Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?

  2021cites this paper
• Perinatal Dietary Polyunsaturated Fatty Acids in Brain Development, Role in Neurodevelopmental Disorders

  2021cites this paper
• Effects of maternal folic acid supplementation on nuclear methyltransferase activity of adult rats subjected to an animal model of schizophrenia

  2021cites this paper
• Association between serum folate levels and schizophrenia based on sex

  2020cites this paper
• Nutritional psychiatry in the treatment of psychotic disorders: Current hypotheses and research challenges

  2020cites this paper
• Relationship between folate, vitamin B12, homocysteine, transaminase and mild cognitive impairment in China: a case-control study

  2020cites this paper
• Overdispersed gene expression in schizophrenia

  2020cites this paper
• Hair Cortisol Is Associated With Social Support and Symptoms in Schizophrenia

  2020cites this paper
• Treatment-resistant schizophrenia: focus on the transsulfuration pathway

  2019cites this paper
• Kininogen-1 as a protein biomarker for schizophrenia through mass spectrometry and genetic association analyses

  2019cites this paper
• Meta-analysis of blood cortisol levels in individuals with first-episode psychosis.

  2019cites this paper
• Role of tissue plasminogen activator and plasminogen activator inhibitor as potential biomarkers in psychosis.

  2019cites this paper
• Assessment of Plasma Vitamin B12 and Folic Acid During Postmenopausal Period

  2019cites this paper
• Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia.

  2019cites this paper
• Roles of 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in early- and late-onset obsessive-compulsive disorder

  2019cites this paper
• Alterations in methionine to homocysteine ratio in individuals with first-episode psychosis and those with at-risk mental state.

  2019cites this paper
• The REVAMP study: research exploring various aspects and mechanisms in preeclampsia: study protocol

  2019cites this paper
• Just say N2O – nitrous oxide misuse: essential information for psychiatrists

  2019cites this paper
• A CRITICAL REVIEW ON HYPOTHESIS, PATHOPHYSIOLOGY OF SCHIZOPHRENIA, AND ROLE OF VITAMINS IN ITS MANAGEMENT

  2018cites this paper
• Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: The effects of FA deficient or FA supplemented diet during the neurodevelopmental phase

  2018cites this paper
• Role of Long Chain Polyunsaturated Fatty Acids in Fetal Programming

  2018cites this paper
• Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models

  2018cites this paper
• Plasma homocysteine in first-episode schizophrenia: 1-year outcome, a prospective study

  2018cites this paper
• CHARACTERIZATION OF PRIMARY AND SECONDARY METABOLITES OF LEAF AND STEM EXTRACTS FROM EURYCOMA LONGIFOLIA JACK

  2018cites this paper
• Natural Medicines for Psychotic Disorders

  2018cites this paper
• Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits

  2018cites this paper
• Adjunctive nutrients in first‐episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms

  2018cites this paper
• Arachidonic Acid Reverses Xanthohumol-Induced Insufficiency in a Human First-Trimester Extravillous Trophoblast Cell Line (HTR-8/SVneo Cells)

  2018cites this paper
• Understanding the impact of environmental stress : the effect of childhood abuse on brain structure and stress response systems in psychosis

  2018cites this paper
• Physiological and Affective Reactivity to Emotional Comments in Individuals at High Risk for Psychosis

  2018cites this paper
• Déficit de ácido fólico y vitamina B12 en niños y adolescentes hospitalizados por un trastorno psiquiátrico

  2017cites this paper
• International Conference on Obesity and Weight Loss Cortisol and Folate and their Roles in Alzheimer’s Disease, Diabetes

  2017cites this paper
• Two‐hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: Study of sex differences and brain oxidative alterations

  2017cites this paper
• Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis

  2017cites this paper
• Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis

  2017cites this paper
• Vitamin B12 Deficiency in Resistant Schizophrenia in Tropics

  2017cites this paper
• Antioxidant and anti‐inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia

  2017influential citation
• Development of GRAS strains for nutraceutical production using systems and synthetic biology approaches: advances and prospects

  2017cites this paper
• Effect of risperidone on serum homocysteine levels in first-episode, drug-naïve patients with schizophrenia.

  2017cites this paper
• Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction

  2017cites this paper
• The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis

  2017cites this paper
• Standardization of Orthoshiphon stamineus Raw Material and Extracts for Anti-Uterine Fibroid

  2017cites this paper
• Supplementation of Maternal Diets with Docosahexaenoic Acid and Methylating Vitamins Impacts Growth and Development of Fetuses from Malnourished Gilts

  2017cites this paper
• Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?

  2017cites this paper
• Epigenetics of Undernutrition

  2017cites this paper
• Medical nutrition in mental health and disorders

  2017cites this paper
• Cortisol and ACTH levels in drug‐naive adolescents with first‐episode early onset schizophrenia

  2017cites this paper
• Maternal long chain polyunsaturated fatty acid status and pregnancy complications.

  2017cites this paper
• Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism.

  2016cites this paper
• A combined supplementation of vitamin B12 and n-3 polyunsaturated fatty acids across two generations improves nerve growth factor and vascular endothelial growth factor levels in the rat hippocampus.

  2016cites this paper
• Adverse Events in Childhood as a Risk Factor for Elevated BMI among People with Schizophrenia and Bipolar Disorder

  2016cites this paper
• Maternal Nutritional Deficiencies and Schizophrenia

  2016cites this paper
• Novel insights into the effect of vitamin B12 and omega-3 fatty acids on brain function

  2016cites this paper
• Hair cortisol in drug-naïve first-episode individuals with psychosis

  2016cites this paper
• Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia

  2016cites this paper
• Efecto de las concentraciones de ritonavir en la farmacocinética de atazanavir: aplicación de técnicas de modelado y simulación farmacocinético poblacional /

  2016cites this paper
• The effect of diet components on the level of cortisol

  2016cites this paper
• DNA Methylation for Prediction of Adverse Pregnancy Outcomes

  2016cites this paper
• Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine.

  2016cites this paper
• Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients

  2016cites this paper
• Emerging Treatments in Schizophrenia: Highlights from Recent Supplementation and Prevention Trials

  2016cites this paper
• Effect of vitamin B12 and omega-3 fatty acid supplementation on brain neurotrophins and cognition in rats: A multigeneration study.

  2016cites this paper
• Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.

  2016cites this paper
• Maternal Fatty Acids and Their Association with Birth Outcome: A Prospective Study

  2016cites this paper